(Q35021708)

5 August 2017

1 reference

title

Hyperoxaluric calcium nephrolithiasis (English)

1 reference

5 August 2017

John R Asplin

1

1 reference

5 August 2017

publication date

1 December 2002

1 reference

Endocrinology and Metabolism Clinics of North America

5 August 2017

published in

1 reference

5 August 2017

volume

31

1 reference

5 August 2017

issue

4

1 reference

5 August 2017

page(s)

927-949

1 reference

The cause of idiopathic calcium stone disease: hypercalciuria or hyperoxaluria?

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Prevalence of hyperoxaluria in idiopathic calcium oxalate kidney stone disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Hyperoxaluria in Patients with Recurrent Calcium Oxalate Calculi: Dietary and Other Risk Factors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

The oxalic acid content of English diets

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Intestinal oxalate and calcium absorption in recurrent renal stone formers and healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Hyperoxaluria in idiopathic calcium stone disease: further evidence of intestinal hyperabsorption of oxalate

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Bioavailability of oxalate in foods

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

A further study of oxalate bioavailability in foods

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Oxalate degradation by microbes of the large bowel of herbivores: the effect of dietary oxalate

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Oxalobacter formigenes gen. nov., sp. nov.: oxalate-degrading anaerobes that inhabit the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Direct quantification of the enteric bacterium Oxalobacter formigenes in human fecal samples by quantitative competitive-template PCR.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Glyoxylate synthesis, and its modulation and influence on oxalate synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Ascorbic Acid Metabolism in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Increase in Urinary Calcium and Oxalate after Fructose Infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

The formation of oxalic acid from the side chain of aromatic amino acids in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

The pathways of oxalate formation from phenylalanine, tyrosine, tryptophan and ascorbic acid in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Plasma calcium-oxalate saturation in children with renal insufficiency and in children with primary hyperoxaluria

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Renal tubular transport of organic acids. Studies with oxalate and para-aminohippurate in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Renal Elimination Kinetics and Plasma Half-Life of Oxalate in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

The Renal Clearance of Oxalate in Normal Subjects and Patients with Primary Hyperoxaluria

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Plasma oxalate and creatinine and oxalate/creatinine clearance ratios in normal subjects and in primary hyperoxaluria. Evidence for renal hyperoxaluria

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Transport of oxalate across the rabbit papillary surface epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Characterization and chromosomal mapping of a genomic clone encoding human alanine:glyoxylate aminotransferase

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Effect of N-terminal alpha-helix formation on the dimerization and intracellular targeting of alanine:glyoxylate aminotransferase

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Identification of mutations associated with peroxisome-to-mitochondrion mistargeting of alanine/glyoxylate aminotransferase in primary hyperoxaluria type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

L-glyceric aciduria. A new genetic variant of primary hyperoxaluria

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

The gene encoding hydroxypyruvate reductase (GRHPR) is mutated in patients with primary hyperoxaluria type II

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Identification and expression of a cDNA for human hydroxypyruvate/glyoxylate reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

PRIMARY HYPEROXALURIA

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

A vertical (pseudodominant) pattern of inheritance in the autosomal recessive disease primary hyperoxaluria type 1: lack of relationship between genotype, enzymic phenotype, and disease severity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Primary hyperoxaluria type 1: diagnostic relevance of mutations and polymorphisms in the alanine:glyoxylate aminotransferase gene (AGXT)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Primary hyperoxaluria type I.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Changing pattern of primary hyperoxaluria in Switzerland

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Results of long-term treatment with orthophosphate and pyridoxine in patients with primary hyperoxaluria

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Long-term prognosis in primary hyperoxaluria type II (L-glyceric aciduria).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Phenotypic expression of primary hyperoxaluria: comparative features of types I and II.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Primary hyperoxaluria type 2

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Primary hyperoxaluria type 2 without L-glycericaciduria: is the disease under-diagnosed?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Hyperoxaluria with hyperglycoluria not due to alanine:glyoxylate aminotransferase defect: a novel type of primary hyperoxaluria

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Transplantation for primary hyperoxaluria in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Glycolate determination detects type I primary hyperoxaluria in dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Response to a physiologic dose of pyridoxine in type I primary hyperoxaluria

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Orthophosphate therapy decreases urinary calcium excretion and serum 1,25-dihydroxyvitamin D concentrations in idiopathic hypercalciuria

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Physicochemical effects of a new slow-release potassium phosphate preparation (UroPhos-K) in absorptive hypercalciuria.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Management of primary hyperoxaluria: efficacy of oral citrate administration

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Use of Magnesium Oxide in Management of Familial Hyperoxaluria

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Kidney transplantation in primary oxalosis: data from the EDTA Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Selective renal transplantation in primary hyperoxaluria type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Transplantation strategies in type 1 primary hyperoxaluria: the issue of pyridoxine responsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Should liver transplantation be performed before advanced renal insufficiency in primary hyperoxaluria type 1?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Combined liver-kidney transplantation in primary hyperoxaluria type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Mechanism for Hyperoxaluria in Patients with Ileal Dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Importance of the colon in enteric hyperoxaluria

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Oxalate degradation by gastrointestinal bacteria from humans

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Renal complications of jejuno-ileal bypass for obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Hyperoxaluria and intestinal disease. The role of steatorrhea and dietary calcium in regulating intestinal oxalate absorption

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Acquired hyperoxaluria with regional enteritis after ileal resection. Role of dietary oxalate

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

High-calcium intake abolishes hyperoxaluria and reduces urinary crystallization during a 20-fold normal oxalate load in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Contribution of dietary oxalate to urinary oxalate excretion

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Urinary oxalate excretion increases with body size and decreases with increasing dietary calcium intake among healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Effects of low calcium diet on urinary calcium and oxalate excretion in patients with idiopathic calcium nephrolithiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Renal oxalate excretion in calcium urolithiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Influence of the calcium content of the diet on the incidence of mild hyperoxaluria in idiopathic renal stone formers

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Relationships between Calcium and Oxalic Acid Intake in the Diet and Their Excretion in the Urine of Normal and Renal-Stone-Forming Subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Modification of dietary oxalate and calcium reduces urinary oxalate in hyperoxaluric patients with kidney stones

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Different dietary calcium intake and relative supersaturation of calcium oxalate in the urine of patients forming renal stones

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Adequacy of a single stone risk analysis in the medical evaluation of urolithiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

The pattern of urinary stone disease in Leeds and in the United Kingdom in relation to animal protein intake during the period 1960-1980.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Dietary changes and the incidence of urinary calculi in the U.K. between 1958 and 1976

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

The Effect of High Animal Protein Intake on the Risk of Calcium Stone-Formation in the Urinary Tract

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Hyperuricosuric calcium oxalate nephrolithiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Dietary influence on serum and urinary oxalate in healthy subjects and oxalate stone formers

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Effects of high intake of dietary animal protein on mineral metabolism and urinary supersaturation of calcium oxalate in renal stone formers

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Acute effects of moderate dietary protein restriction in patients with idiopathic hypercalciuria and calcium nephrolithiasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Relationship of protein intake to urinary oxalate and glycolate excretion

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Effect of animal and vegetable protein intake on oxalate excretion in idiopathic calcium stone disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Sensitivity to meat protein intake and hyperoxaluria in idiopathic calcium stone formers

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Absence of effect of allopurinol on oxalate excretion by stone patients on random and controlled diets.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

The effect of ascorbic acid ingestion on the biochemical and physicochemical risk factors associated with calcium oxalate kidney stone formation.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Effect of megadoses of ascorbic acid on serum and urinary oxalate.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Relative hyperoxaluria, crystalluria and haematuria after megadose ingestion of vitamin C.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Acute renal failure, oxalosis, and vitamin C supplementation: a case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

A prospective study of the intake of vitamins C and B6, and the risk of kidney stones in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

Oxalate content of soybean seeds (Glycine max: Leguminosae), soyfoods, and other edible legumes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2802%2900030-0

7 January 2021

10.1016/S0889-8529(02)00030-0

Identifiers

DOI

1 reference

5 August 2017

1 reference